USRE44339E1 - N-substituted P-menthane carboxamides - Google Patents
N-substituted P-menthane carboxamides Download PDFInfo
- Publication number
- USRE44339E1 USRE44339E1 US13/222,947 US201113222947A USRE44339E US RE44339 E1 USRE44339 E1 US RE44339E1 US 201113222947 A US201113222947 A US 201113222947A US RE44339 E USRE44339 E US RE44339E
- Authority
- US
- United States
- Prior art keywords
- menthanecarboxamide
- product
- compound
- menthyl
- cyanomethylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 N-substituted P-menthane carboxamides Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 45
- 238000001816 cooling Methods 0.000 claims abstract description 31
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- FPJRGEOLQICYQZ-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-UHFFFAOYSA-N 0.000 claims description 8
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 claims description 7
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 claims description 6
- 229930007503 menthone Natural products 0.000 claims description 6
- LXPSLQYJADBSNA-UHFFFAOYSA-N 5-methyl-2-propan-2-yl-n-(4-sulfamoylphenyl)cyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(S(N)(=O)=O)C=C1 LXPSLQYJADBSNA-UHFFFAOYSA-N 0.000 claims description 5
- 230000035597 cooling sensation Effects 0.000 claims description 5
- 229940041616 menthol Drugs 0.000 claims description 5
- 239000002324 mouth wash Substances 0.000 claims description 5
- CFAIGEXTVUJYJT-UHFFFAOYSA-N n-(3-hydroxy-4-methoxyphenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound C1=C(O)C(OC)=CC=C1NC(=O)C1C(C(C)C)CCC(C)C1 CFAIGEXTVUJYJT-UHFFFAOYSA-N 0.000 claims description 5
- IPINMMIMRHRFEG-UHFFFAOYSA-N n-(4-acetylphenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(C(C)=O)C=C1 IPINMMIMRHRFEG-UHFFFAOYSA-N 0.000 claims description 5
- XGIZWERJPUCCKV-UHFFFAOYSA-N n-(4-cyanophenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(C#N)C=C1 XGIZWERJPUCCKV-UHFFFAOYSA-N 0.000 claims description 5
- FAPXMWNLKPZDBE-UHFFFAOYSA-N n-[4-(hydroxymethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(CO)C=C1 FAPXMWNLKPZDBE-UHFFFAOYSA-N 0.000 claims description 5
- 235000019505 tobacco product Nutrition 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 4
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 claims description 3
- RQXTZKGDMNIWJF-UHFFFAOYSA-N 2-butan-2-ylcyclohexan-1-one Chemical compound CCC(C)C1CCCCC1=O RQXTZKGDMNIWJF-UHFFFAOYSA-N 0.000 claims description 3
- RCORSHSFJCXHTF-UHFFFAOYSA-N 2-ethenyl-1,3-dioxan-5-ol Chemical compound OC1COC(C=C)OC1 RCORSHSFJCXHTF-UHFFFAOYSA-N 0.000 claims description 3
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 claims description 3
- CTMTYSVTTGVYAW-FRRDWIJNSA-N 5-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxy-5-oxopentanoic acid Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCCC(O)=O CTMTYSVTTGVYAW-FRRDWIJNSA-N 0.000 claims description 3
- BLILOGGUTRWFNI-UHFFFAOYSA-N Monomenthyl succinate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(O)=O BLILOGGUTRWFNI-UHFFFAOYSA-N 0.000 claims description 3
- RWAXQWRDVUOOGG-UHFFFAOYSA-N N,2,3-Trimethyl-2-(1-methylethyl)butanamide Chemical compound CNC(=O)C(C)(C(C)C)C(C)C RWAXQWRDVUOOGG-UHFFFAOYSA-N 0.000 claims description 3
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000551 dentifrice Substances 0.000 claims description 3
- 230000037406 food intake Effects 0.000 claims description 3
- 229940095045 isopulegol Drugs 0.000 claims description 3
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 229940051866 mouthwash Drugs 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- NHJCIRQKFWBUMK-UHFFFAOYSA-N CC.CC.CC1CCC(C(C)C)C(C(=O)CCC2=CC=CC=C2)C1.C[Y] Chemical compound CC.CC.CC1CCC(C(C)C)C(C(=O)CCC2=CC=CC=C2)C1.C[Y] NHJCIRQKFWBUMK-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical compound NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- XZZVZSVCQGUKOJ-UHFFFAOYSA-N 5-methyl-2-propan-2-ylcyclohexane-1-carbonyl chloride Chemical compound CC(C)C1CCC(C)CC1C(Cl)=O XZZVZSVCQGUKOJ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 229910006074 SO2NH2 Inorganic materials 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 150000003975 aryl alkyl amines Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/61—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Definitions
- Cooling compounds that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.
- cooling compounds can be represented by formula I
- Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4 straight or branched alkoxy;
- X is (CH 2 ) n —R, where n is 0 or 1 and R is a group with non-bonding electrons, with the provisos that:
- An embodiment provides for compounds of formula I wherein X is in the 4-position. Additional embodiments provide for compounds of formula I wherein X is in the 4-position and Y and Z are H, OH, Me or OMe. In certain embodiments, Y and Z are selected independently.
- Useful groups with non-bonding electrons are halogens, OH, OMe, NO 2 , CN, Ac, SO 2 NH 2 , CHO, CO 2 H and C 1 -C 4 alkyl carboxylates such as CO 2 Et.
- Other C 1 -C 4 alkyl carboxylates with non-bonding electrons may be useful.
- the compounds of formula I have 3 chiral centres, giving rise to 8 stereoisomers. All possible stereoisomers are included in the scope of the compounds represented by formula I.
- the cooling compounds may be prepared by reacting an arylalkylamine derivative with an appropriate acid chloride or carbonyl chloride.
- the carbonyl chloride can be prepared from 1-menthol ((1R,2S,5R)-2-isopropyl-5-methylcyclohexanol).
- the cooling compounds are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 10 times higher than that of similar known compounds) and by the longevity of the cooling effect, which adds to their attractiveness in a large variety of products.
- the subject cooling compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation.
- applying is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation.
- applying to the skin it may be, for example, by including the compound in a cream or salve, or in a sprayable composition.
- a method is directed to providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound as hereinabove described.
- the subject cooling compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (FrescolatTM ML), menthone glycerine acetal (FrescolatTM MGA), mono-menthyl succinate (PhyscoolTM), mono-menthyl glutarate, O-menthyl glycerine (CoolActTM 10), menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone (FreskomentheTM).
- other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-tri
- the starting compound p-menthane-3-carbonyl chloride as used for the preparation of the compounds in Example 1-6 was prepared from 1-menthol.
- the ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An intense cooling is felt in every area of the mouth as well as the lips. The cooling perception lasts for several hours.
- Peppermint oil Terpeneless 0.500 g
- the materials are mixed in the toothgel, and a panelist's teeth are brushed using this toothgel.
- the mouth is rinsed with water and the water spit out.
- An intense cooling sensation is felt by the panelist in all areas of the mouth. The cooling perception lasts for several hours.
Abstract
Cooling compounds are provided having the formula:
wherein, m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4 straight or branched alkoxy, X is (CH2)n—R, where n is 0 or 1 and R is a group with non-bonding electrons, with the provisos that: (a) when Y and Z are H, X is not F, OH, MeO or NO2 in the 4-position and is not OH in the 2 or 6-position (b) when Y or Z is H then X, Y and Z are such that
-
- (i) the groups in the 3- and 4-positions are not both OMe,
- (ii) the groups in the 4- and 5-positions are not both OMe,
- (iii) the groups in 3- and 5-positions are not OMe if the group in the 4-position is OH, and
- (iv) the groups in the 3- and 5-positions are not OH if the group in the 4-position is methyl.
Description
This application is a reissue application of U.S. Ser. No. 11/437,294 filed May 19, 2006, now U.S. Pat. No. 7,414,152, which is a continuation-in-part of International Application No. PCT/CH2004/000646 filed Oct. 28, 2004, under 35 USC §120 and §365(c), and which claims the benefit of the filing date of U.S. Provisional Application No. 60/523,977 filed Nov. 21, 2003.
Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, tobacco products, beverages, dentifrices, mouthwashes and toiletries.
One class of cooling compounds that have enjoyed substantial success consists of N-substituted p-menthane carboxamides. Examples of these compounds are described in, for example, British Patents GB 1,351,761-2 and U.S. Pat. No. 4,150,052.
It has now been found that a particular selection of such compounds exhibits a cooling effect that is both surprisingly strong and long-lasting. In one embodiment, the cooling compounds can be represented by formula I
in which m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4 straight or branched alkoxy; X is (CH2)n—R, where n is 0 or 1 and R is a group with non-bonding electrons, with the provisos that:
- (a) when Y and Z are H, X is not F, OH, MeO or NO2 in the 4-position and is not OH in the 2 or 6-position
- (b) when Y or Z is H then X, Y and Z are such that
- (i) the groups in the 3- and 4-positions are not both OMe,
- (ii) the groups in the 4- and 5-positions are not both OMe,
- (iii) the groups in 3- and 5-positions are not OMe if the group in the 4-position is OH, and
- (iv) the groups in the 3- and 5-positions are not OH if the group in the 4-position is methyl.
An embodiment provides for compounds of formula I wherein X is in the 4-position. Additional embodiments provide for compounds of formula I wherein X is in the 4-position and Y and Z are H, OH, Me or OMe. In certain embodiments, Y and Z are selected independently.
Useful groups with non-bonding electrons are halogens, OH, OMe, NO2, CN, Ac, SO2NH2, CHO, CO2H and C1-C4 alkyl carboxylates such as CO2Et. Other C1-C4 alkyl carboxylates with non-bonding electrons may be useful.
The compounds of formula I have 3 chiral centres, giving rise to 8 stereoisomers. All possible stereoisomers are included in the scope of the compounds represented by formula I.
The cooling compounds may be prepared by reacting an arylalkylamine derivative with an appropriate acid chloride or carbonyl chloride. The carbonyl chloride can be prepared from 1-menthol ((1R,2S,5R)-2-isopropyl-5-methylcyclohexanol).
The cooling compounds are distinguished from similar compounds of the prior art by their surprisingly high cooling effect (up to 10 times higher than that of similar known compounds) and by the longevity of the cooling effect, which adds to their attractiveness in a large variety of products.
For example, a small group of panelists was asked to taste various solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2 ppm. In a second experiment, the same panel was asked to taste the solutions at the chosen concentrations and to record the cooling intensity at regular time intervals until no cooling could be sensed in the mouth. Results are shown in table 1.
TABLE 1 |
experiment on cooling intensity and longevity. |
Chemical | Concentration | Longevity |
1-Menthol | 2.0 ppm | 35 minutes |
N-ethyl p-menthanecarboxamide (WS-3) | 1.5 ppm | 57 minutes |
Formula 1, m = 0,Y = Z = H, | 0.5 ppm | 90 minutes |
X = 4-CN | ||
Formula 1, m = 0, Y = Z = H, | 0.2 ppm | 93 minutes |
X = 4-CH2CN | ||
From Table 1, it can be seen that the compounds of Formula I are up to 10 times stronger and last up to 3 times longer than menthol, the reference cooling compound. Compounds of Formula I are also much stronger and last longer than WS-3, a known cooling compound of the prior art.
The subject cooling compounds may be used in products that are applied to the mouth or the skin to give a cooling sensation. By “applying” is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation. In the case of application to the skin, it may be, for example, by including the compound in a cream or salve, or in a sprayable composition. A method is directed to providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound as hereinabove described.
The subject cooling compounds may be used alone or in combination with other cooling compounds known in the art, e.g., menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), menthyl lactate (Frescolat™ ML), menthone glycerine acetal (Frescolat™ MGA), mono-menthyl succinate (Physcool™), mono-menthyl glutarate, O-menthyl glycerine (CoolAct™ 10), menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone (Freskomenthe™).
The subject cooling compounds and related methods are further described by the following non-limiting examples.
The starting compound p-menthane-3-carbonyl chloride as used for the preparation of the compounds in Example 1-6 was prepared from 1-menthol.
To a flask, were added 6.6 g (50 mmol) of 4-aminobenzyl cyanide, 4.04 mL of pyridine and 100 mL MtBE. To this mixture, 10 g of p-menthane-3-carbon*yl chloride were added dropwise over 5 minutes. The reaction mixture was stirred for 24 h. To the reaction mixture, 50 mL of water were added. The mixture was separated. The organic layer was washed with 50 mL of water and 50 mL of brine. The organic layer was dried over MgSO4. The solvent was evaporated in vacuo to afford the crude product, which was recrystallized from hexanes to afford 10.1 g of the desired product with the following spectroscopic properties:
MS: 299 ([M+1]), 298 ([M+]), 132, 83. 1H NMR (300 MHz; CDCl3) δ; 7.58 (d, 2H), 7.49 (s, 1H), 7.27 (d, 2H), 3.73 (s, 2H), 2.2 (t, 1H), 1.96-1.57 (m, 5H), 1.48-1.21 (m, 2H), 1.172-0.99 (m, 2H), 0.94 (d, 3H), 0.93 (d, 3H), 0.85 (d, 3H). 13C NMR (75 MHz; CDCl3)δ: 174.4, 137.8, 128.3, 125.1, 120.3, 118.2, 50.5, 44.3, 39.25, 34.3, 32.1, 28.7, 23.8, 22.9, 22.1, 21.2, 16.1
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 339 ([M+1]), 338 ([M+]), 172, 83. 1H NMR (300 MHz; DMSO) δ: 10.21 (s, 1H), 7.76 (d, 1H) 7.73 (d, 2H), 7.23 (s, 2H), 2.26-2.42 (m, 1H), 1.45-1.85 (m, 5H), 1.29-1.44 (m, 2H), 0.89 (d, 3H), 0.86 (d, 3H), 0.78 (d, 3H). 13C NMR (75 MHz; DMSO) δ: 174.6, 142.3, 138.3, 126.7, 118.8, 48.9, 43.7, 34.3, 31.9, 28.6, 23.7, 22.35, 21.3, 16.25
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 285 ([M+1]), 284 ([M+]), 139, 83. 1H NMR (300 MHz; CDCl3) δ: 7.69 (d, 2H), 7.6 (d, 2 H), 7.5 (s, 1H), 1.85-1.97 (m, 1H), 1.69-1.84 (m, 3H), 1.55-1.69 (m, 2H), 1.21-1.47 (m, 2H), 0.979-1.16 (m, 2H), 0.95 (d, 3H), 0.93 (d, 3H), 0.82 (d, 3H). 13C NMR (300 MHz; CDCl3) δ: 174.6, 133.1, 119.4, 118.7, 100.35, 50.7, 44.4, 39.25, 34.2, 32.1, 28.8, 23.7, 22.0, 21.2, 16.1, 14.0
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 302 ([M+1]), 301 ([M+]), 135, 83. 1H NMR (300 MHz; CDCl3) δ: 7.93 (d, 2H), 7.66 (d, 2H), 7.63 (s, 1H), 2.57 (s, 3H), 2.09-2.31 (m, 1H), 1.84-1.98 (m, 1H), 1.68-1.85 (m, 5H), 1.56-1.68 (m, 1H), 1.17-1.48 (m, 2H), ), 0.93 (d, 3H), 0.91 (d, 3H), 0.83 (d, 3H). 13C NMR (75 MHz; CDCl3) δ: 197.1, 174.9, 142.7, 129.9, 119.2, 51.2, 44.9, 39.8, 34.8, 32.6, 29.2, 26.6, 24.3, 22.4, 21.5, 16.6
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 290 (M+1), 289 (M+), 123, 83. 1HNMR (300 MHz, DMSO) δ: 9.9 (s, 1H), 7.54 (d, 2H), 7.21 (d, 2H), 4.2 (s, 2H), 2.36-2.1 (m, 1H), 1.8-1.59 (m, 6H), 1.57-1.44 (m, 1H), 1.21-0.9 (m, 4H), 0.87 (dd, 3H), 0.85 (dd, 3H), 0.79 (d, 2H). 13C NMR (75 MHz; DMSO) δ: 173.7, 137.7, 137.1, 126.7, 118.9, 62.6, 48.6, 43.6, 34.2, 31.7, 28.3, 23.6, 22.2, 21.1, 16.1
A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:
MS: 306 ([M+1]), 305 ([M+]), 139, 83. 1H NMR (300 MHz; CDCl3) δ: 7.14 (s, 1H), 7.08 (d, 1H), 6.78 (d, 1H), 5.7 (s, 1H), 3.8 (s, 3H), 2.02-2.21 (m, 2H), 1.53-1.94 (m, 5H), 1.17-1.48 (m, 2H), 0.97-1.17 (m, 2H), 0.92 (dd, 3H), 0.91 (dd, 3H), 0.82 (d, 3H). 13C NMR (75 MHz; CDCl3) δ: 173.9, 145.6, 143.3, 131.7, 111.65, 110.8, 107.4, 56.1, 50.5, 44.4, 39.2, 32.15, 34.4, 28.6, 23.8, 22.1, 21.2, 16.1
Alcohol 95% | 177 | mL | ||
Sorbitol 70% | 250 | g | ||
Compound of example 1 as a 1% solution in alcohol | 50 | mL | ||
Peppermint oil, Terpeneless | 0.300 | g | ||
Methyl salicylate | 0.640 | g | ||
Eucalyptol | 0.922 | g | ||
Thymol | 0.639 | g | ||
Benzoic acid | 1.500 | g | ||
Pluronic ™ F127 | 5.000 | g | ||
Sodium Saccharin | 0.600 | g | ||
Sodium Citrate | 0.300 | g | ||
Citric Acid | 0.100 | g | ||
Water | q.s. 1 | liter | ||
The ingredients are mixed. 30 mL of obtained solution is put in the mouth, swished around, gargled and spit out. An intense cooling is felt in every area of the mouth as well as the lips. The cooling perception lasts for several hours.
Opaque toothgel 97.000 g
Compound of example 2 as a 2% solution in PG 2.500 g
Peppermint oil, Terpeneless 0.500 g
The materials are mixed in the toothgel, and a panelist's teeth are brushed using this toothgel. The mouth is rinsed with water and the water spit out. An intense cooling sensation is felt by the panelist in all areas of the mouth. The cooling perception lasts for several hours.
It will be understood that the embodiments described herein are merely exemplary, and that one skilled in the art may make variations and modifications without departing from the spirit and scope of the invention. All such variations and modifications are intended to be included within the scope of the invention as described hereinabove. Further, all embodiments disclosed are not necessarily in the alternative, as various embodiments of the invention may be combined to provide the desired result.
Claims (23)
1. A compound selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide.
2. A method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound according to claim 1 selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide.
3. A product that is applied to the mouth or the skin foodstuff, tobacco product, beverage, dentrifice, mouthwash, or toiletry composition comprising an amount of a compound according to claim 1 selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide, wherein the amount is effective to give a cooling sensation to the mouth or the skin.
4. A compound comprising formula I
in which m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and C1-C4 straight or branched alkoxy; X is (CH2)n—R, where n is 0 or 1 and R is a group with non-bonding electrons; said compound selected from the group consisting of N-(4-cyanomethylphenyl) p-menthanecarboxamide, N-(4-sulfamoylphenyl) p-menthanecarboxamide, N-(4-cyanophenyl) p-menthanecarboxamide, N-(4-acetylphenyl) p-menthanecarboxamide, N-(4-hydroxymethylphenyl) p-menthanecarboxamide and N-(3-hydroxy-4-methoxyphenyl) p-menthanecarboxamide.
5. A method of providing a cooling effect to the mouth or skin by applying thereto a product comprising a compound according to claim 4 .
6. A product that is applied to the mouth or the skin comprising an amount of a compound according to claim 4 , wherein the amount is effective to give a cooling sensation to the mouth or the skin.
7. The product of claim 6 comprising at least one of foodstuffs, tobacco products, beverages, dentifrices, mouthwashes, or toiletries.
8. The product composition of claim 7 comprising 3 wherein the product comprises a cream or salve.
9. The product composition of claim 7 comprising 3 wherein the product comprises a sprayable composition.
10. The product of claim 6 further comprising an additional cooling compound.
11. The product of claim 10 wherein the additional cooling compound comprises at least one of menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide, N,2,3-trimethyl-2-isopropylbutanamide, menthyl lactate, menthone glycerine acetal, mono-menthyl succinate, mono-menthyl glutarate, O-menthyl glycerine, menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone.
12. The method of claim 5 wherein said applying comprises inhalation.
13. The method of claim 5 wherein said applying comprises oral ingestion.
14. The product of claim 3 comprising at least one of foodstuffs, tobacco products, beverages, dentifrices, mouthwashes, or toiletries.
15. The product of claim 14 comprising a cream or salve.
16. The product of claim 14 comprising a sprayable composition.
17. The product composition of claim 3 further comprising an additional cooling compound.
18. The product composition of claim 17 wherein the additional cooling compound comprises at least one of menthol, menthone, isopulegol, N-ethyl p-menthanecarboxamide, N,2,3-trimethyl-2-i sopropylbutanami de, menthyl lactate, menthone glycerine acetal, mono-menthyl succinate, mono-menthyl glutarate, O-menthyl glycerine, menthyl-N,N-dimethylsuccinamate or 2-sec-butylcyclohexanone.
19. The method of claim 2 wherein said applying comprises inhalation.
20. The method of claim 2 wherein said applying comprises oral ingestion.
21. The compound of claim 1, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
22. The method of claim 2, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
23. The composition of claim 3, wherein said compound is N-(4-cyanomethylphenyl) p-menthanecarboxamide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/222,947 USRE44339E1 (en) | 2003-11-21 | 2011-08-31 | N-substituted P-menthane carboxamides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52397703P | 2003-11-21 | 2003-11-21 | |
PCT/CH2004/000646 WO2005049553A1 (en) | 2003-11-21 | 2004-10-28 | N-substituted p-menthane carbosamided |
US11/437,294 US7414152B2 (en) | 2003-11-21 | 2006-05-19 | N-substituted p-menthane carboxamides |
US13/222,947 USRE44339E1 (en) | 2003-11-21 | 2011-08-31 | N-substituted P-menthane carboxamides |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/437,294 Reissue US7414152B2 (en) | 2003-11-21 | 2006-05-19 | N-substituted p-menthane carboxamides |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE44339E1 true USRE44339E1 (en) | 2013-07-02 |
Family
ID=34619622
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/437,294 Ceased US7414152B2 (en) | 2003-11-21 | 2006-05-19 | N-substituted p-menthane carboxamides |
US13/222,947 Active USRE44339E1 (en) | 2003-11-21 | 2011-08-31 | N-substituted P-menthane carboxamides |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/437,294 Ceased US7414152B2 (en) | 2003-11-21 | 2006-05-19 | N-substituted p-menthane carboxamides |
Country Status (10)
Country | Link |
---|---|
US (2) | US7414152B2 (en) |
EP (1) | EP1685093B3 (en) |
JP (1) | JP4786544B2 (en) |
CN (1) | CN100582089C (en) |
AT (1) | ATE464283T1 (en) |
BR (1) | BRPI0416770B1 (en) |
DE (1) | DE602004026619D1 (en) |
ES (1) | ES2342466T7 (en) |
PL (1) | PL1685093T6 (en) |
WO (1) | WO2005049553A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
US10871363B2 (en) | 2018-05-28 | 2020-12-22 | The Procter & Gamble Company | Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity |
US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US11236042B2 (en) | 2017-01-10 | 2022-02-01 | Takasago International Corporation | Methylmenthol derivative and cool-sensation imparter composition containing same |
US11344488B2 (en) | 2017-10-16 | 2022-05-31 | Takasago International Corporation | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative |
Families Citing this family (171)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2352563T3 (en) * | 2005-03-01 | 2011-02-21 | Givaudan Sa | MENTANOCARBOXAMIDE DERIVATIVES THAT HAVE COOLING PROPERTIES. |
GB0504194D0 (en) * | 2005-03-02 | 2005-04-06 | Givaudan Sa | Organic compounds |
BRPI0610087A2 (en) * | 2005-05-27 | 2008-12-02 | Givaudan Sa | cooling compound |
JP5383191B2 (en) | 2005-08-15 | 2014-01-08 | ジボダン エス エー | Refreshing compound |
EP1940791B1 (en) * | 2005-10-25 | 2009-09-16 | Givaudan SA | Organic compounds |
EP1996535A2 (en) * | 2006-03-15 | 2008-12-03 | Givaudan SA | Para-substituted 2-alkoxyphenol compounds |
US20090312384A1 (en) * | 2006-07-14 | 2009-12-17 | Stefan Michael Furrer | Benzimidazole As Cooling Compounds |
BRPI0721140A2 (en) * | 2006-12-20 | 2014-04-01 | Givaudan Nederland Services Bv | P-MENTANE-3-N-REPLACED CARBOXAMIDE AND USES OF THE SAME. |
GB0704163D0 (en) * | 2007-03-02 | 2007-04-11 | Quest Int Serv Bv | Compositions comprising a physiological coolant |
JP2010527943A (en) | 2007-05-23 | 2010-08-19 | ジボダン エス エー | Buton derivatives useful as coolants |
EP2162018B1 (en) | 2007-06-06 | 2012-10-17 | Givaudan SA | Salt enhancement |
US8655677B2 (en) * | 2007-06-12 | 2014-02-18 | Bruce Reiner | Productivity workflow index |
WO2008151460A2 (en) | 2007-06-13 | 2008-12-18 | Givaudan Sa | Cooling compounds |
US7880011B2 (en) | 2007-07-23 | 2011-02-01 | Givandan, S.A. | Amide addition reaction |
EP2033688B1 (en) | 2007-08-20 | 2012-10-17 | Symrise AG | Oxalic acid derivatives and their use as physiological cooling agents |
US20090098173A1 (en) * | 2007-10-11 | 2009-04-16 | Robinson Ronni L | Topical pain relief product |
WO2009062332A2 (en) * | 2007-11-16 | 2009-05-22 | Givaudan Sa | Cooling compounds |
WO2009070910A2 (en) | 2007-12-07 | 2009-06-11 | Givaudan Sa | Carboxamide derivatieves having cooling properties |
WO2009076792A1 (en) | 2007-12-19 | 2009-06-25 | Givaudan Sa | Cooling compounds |
EP2250154A1 (en) * | 2008-01-17 | 2010-11-17 | Givaudan SA | Benzimidazole derivatives and their use as cooling agents |
EP2244745B1 (en) * | 2008-02-22 | 2015-03-25 | The Procter and Gamble Company | Absorbent article comprising lotion composition comprising a cooling agent |
DE102008015425A1 (en) * | 2008-03-20 | 2010-01-21 | Beiersdorf Ag | Cosmetic or dermatological preparations for the reduction of itching and other dermatological abnormalities, which may occur particularly in the case of aging skin, containing (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridine-2-) yl) ethylcyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) -phenyl) -2-isopropyl-5-methylcyclohexanecarboxamide |
DE102008015424A1 (en) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Cooling cosmetic or dermatological preparations containing (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyn-2-yl) -ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) -phenyl) -2-isopropyl-5-methylcyclohexanecarboxamide with menthoxypropanediol |
DE102008015426A1 (en) | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Cooling cosmetic or dermatological preparations containing (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridyn-2-yl) -ethyl-cyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) -phenyl) -2-isopropyl-5-methylcyclohexanecarboxamide to reduce reddening of the skin |
DE102008015428A1 (en) * | 2008-03-20 | 2009-09-24 | Beiersdorf Ag | Cooling preparations for human skin and / or mucosal contact containing (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2- (pyridin-2-yl) -ethyl-cyclohexanecarboxamide and / or ( 1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexanecarboxamide |
EP2296759B1 (en) * | 2008-05-22 | 2019-10-02 | Givaudan SA | Cooling composition |
AU2009282004A1 (en) * | 2008-08-15 | 2010-02-18 | The Procter & Gamble Company | Solution of menthane carboxamides for use in consumer products |
BRPI0917999A2 (en) * | 2008-08-15 | 2015-11-17 | Procter & Gamble | synthesis of cyclohexane derivatives useful as sensory elements in consumer products |
AU2009318056B2 (en) * | 2008-11-20 | 2014-07-24 | The Procter & Gamble Company | Personal care compositions providing enhanced cooling sensation |
FR2944790B1 (en) * | 2009-04-23 | 2012-06-01 | Mane Fils V | NOVEL COMPOUNDS WITH PHYSIOLOGICAL EFFECT |
US7923577B2 (en) | 2009-04-27 | 2011-04-12 | International Flavors & Fragrances Inc. | Menthylcarboxamides and their use as cooling agents |
US8664261B2 (en) | 2009-05-05 | 2014-03-04 | Givaudan S.A. | Organic compounds having cooling properties |
BR112012001599A2 (en) | 2009-07-29 | 2016-03-08 | Unilever Nv | dentifrice composition |
US20120196018A1 (en) * | 2009-07-29 | 2012-08-02 | Francisco Valentino Villagran | Organic Compounds |
EP2295031B1 (en) | 2009-08-05 | 2018-01-10 | Symrise AG | Use of pterocarpans as anti-cellulite agents |
CN102802732B (en) | 2009-09-11 | 2016-04-27 | 宝洁公司 | For the method and composition of oral surfaces hydrophobically modified |
US20110195042A1 (en) | 2010-02-10 | 2011-08-11 | Thomas Edward Huetter | Compositions, Methods and Kits Useful for Treating a Respiratory Symptom |
EP2553444B1 (en) | 2010-04-01 | 2018-09-26 | The Procter and Gamble Company | Whole mouth malodor control by a combination of antibacterial and deodorizing agents |
EP2555745B1 (en) | 2010-04-08 | 2016-12-21 | Symrise AG | Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol |
EP2389922A1 (en) | 2010-05-25 | 2011-11-30 | Symrise AG | Cyclohexyl carbamate compounds as anti-ageing actives |
BR112013001142A2 (en) | 2010-07-19 | 2016-05-17 | Procter & Gamble | compositions comprising derivatives of essential oil compounds and use in personal care products |
EP2613649A1 (en) | 2010-09-09 | 2013-07-17 | Kraft Foods Global Brands LLC | Chewing gum compositions providing flavor release profiles |
AU2011308857B2 (en) | 2010-10-01 | 2015-11-05 | The Procter & Gamble Company | Oral care compositions with improved flavor |
US20120116113A1 (en) | 2010-11-05 | 2012-05-10 | Erman Mark B | PROCESS FOR MAKING NEO-ENRICHED p-MENTHANE COMPOUNDS |
EP2286908A3 (en) | 2010-11-19 | 2011-06-01 | Symrise AG | Solubilizer for cosmetic preparations |
EP2356977B1 (en) | 2011-02-02 | 2017-12-27 | Symrise AG | Preparations with wood extracts of Gleditsia |
AU2012217908B2 (en) | 2011-02-14 | 2016-03-03 | The Procter & Gamble Company | Filmcoated solid dosage forms comprising honey in the coating |
WO2013014235A2 (en) | 2011-07-26 | 2013-01-31 | Givaudan Sa | Rinse-off compositions |
US20130042482A1 (en) | 2011-08-16 | 2013-02-21 | Valerie Jean Bradford | Skin Engaging Member Comprising An Anti-Irritation Agent |
ES2689171T3 (en) | 2011-09-01 | 2018-11-08 | The Procter & Gamble Company | Compositions for oral care with improved rheology |
US9802885B2 (en) | 2011-09-01 | 2017-10-31 | Takasago International Corporation (Usa) | Substituted cyclohexane compounds |
GB201205444D0 (en) * | 2012-03-28 | 2012-05-09 | Givaudan Sa | Composition |
BR112014027633A2 (en) * | 2012-05-22 | 2017-06-27 | Unilever Nv | personal care composition, methods for providing a refreshing feel and use of a copolymer |
US20130315843A1 (en) | 2012-05-25 | 2013-11-28 | The Procter & Gamble Company | Composition for reduction of trpa1 and trpv1 sensations |
EP2861304B1 (en) | 2012-06-15 | 2018-08-08 | Symrise AG | Compositions comprising hyaluronan biosynthesis promoting agents |
US20130344120A1 (en) | 2012-06-21 | 2013-12-26 | Douglas Craig Scott | Mouth Rinse Emulsions |
WO2014005614A1 (en) | 2012-07-02 | 2014-01-09 | Symrise Ag | A method of flavouring a smoking product |
EP2695597B1 (en) | 2012-08-07 | 2019-07-24 | Symrise AG | Cosmetic compositions |
US20140090255A1 (en) * | 2012-09-28 | 2014-04-03 | The Gillette Company | Skin Engaging Member Comprising At Least One Thermally Resilient Sensate |
SG11201501430VA (en) | 2012-09-28 | 2015-03-30 | Gillette Co | A skin engaging member comprising at least one thermally resilient sensate |
WO2014052389A2 (en) * | 2012-09-28 | 2014-04-03 | The Gillette Company | A skin engaging shaving aid member comprising at least one thermally resilient sensate |
EP2745878B1 (en) | 2012-12-19 | 2023-01-25 | Symrise AG | Cosmetic compositions |
AU2014209162B2 (en) | 2013-01-25 | 2016-03-24 | Wintermute Biomedical, Llc | Therapeutic compounds |
EP2764860A1 (en) | 2013-02-06 | 2014-08-13 | Basf Sa | Cupuassu fatty acid amidoamines and their derivatives |
CA2899492C (en) | 2013-02-13 | 2019-09-17 | The Procter & Gamble Company | Anise flavored medication |
ES2701758T3 (en) | 2013-02-27 | 2019-02-25 | Symrise Ag | Ginger extract for the protection of stem cells |
ES2647784T3 (en) | 2013-03-08 | 2017-12-26 | Symrise Ag | Cosmetic compositions |
PL2774481T3 (en) | 2013-03-08 | 2019-03-29 | Symrise Ag | Antimicrobial compositions |
EP2783578A1 (en) | 2013-03-26 | 2014-10-01 | Symrise AG | Catechin reaction products |
EP2789369B1 (en) | 2013-04-14 | 2018-06-06 | Symrise AG | A composition for lightening skin and hair |
EP2807925A1 (en) | 2013-05-26 | 2014-12-03 | Symrise AG | Antimicrobial compositions |
EP2810934A1 (en) | 2013-06-09 | 2014-12-10 | Symrise AG | New succinate derivatives |
EP3127583A1 (en) | 2013-06-24 | 2017-02-08 | The Procter and Gamble Company | A method of demonstrating stain-proof efficacy of an oral care composition |
EP2842607B1 (en) | 2013-09-02 | 2018-05-30 | Symrise AG | A skin and/or hair whitening mixture |
EP3046634A1 (en) | 2013-09-22 | 2016-07-27 | Cutech S.R.L. | Extracts fo halimione portulacoides and their application |
EP2853254B1 (en) | 2013-09-26 | 2017-11-08 | Symrise AG | A composition for lightening skin and/or hair |
EP2859883B1 (en) | 2013-10-13 | 2019-05-15 | Symrise AG | Active mixtures comprising acylated oligopeptides and troxerutin |
EP2862852B1 (en) | 2013-10-18 | 2018-07-04 | Symrise AG | Urea derivatives for the protection of stem cells |
WO2015062629A1 (en) | 2013-10-29 | 2015-05-07 | Cutech Srl | Use of mono ornithine ketoglutarate (mokg) |
US9884130B2 (en) | 2013-11-13 | 2018-02-06 | The Procter & Gamble Company | Compositions for delivery of oral comfort sensations |
EP3110510A1 (en) | 2014-02-27 | 2017-01-04 | The Procter & Gamble Company | Oral care compositions with a reduced bitter taste perception |
ES2643590T3 (en) | 2014-03-18 | 2017-11-23 | Symrise Ag | Titanium dioxide coated to reduce the effect of skin whitening |
US20150272847A1 (en) * | 2014-03-26 | 2015-10-01 | The Gillette Company | Skin Engaging Shaving Aid Comprising A Thermally Resilient Sensate And A TRPA1 Receptor Inhibitor |
US20150273711A1 (en) * | 2014-03-26 | 2015-10-01 | The Gillette Company | Razor Comprising A Molded Shaving Aid Composition Comprising A Thermally Resilient Sensate |
AU2015249706A1 (en) | 2014-04-23 | 2016-11-03 | The Procter & Gamble Company | Cyclohexanecarboxamide with cooling properties |
EP2962678A1 (en) | 2014-06-30 | 2016-01-06 | Symrise AG | Flavour and fragrance compositions comprising acetophenone derivatives |
EP2979682B1 (en) | 2014-07-30 | 2018-09-05 | Symrise AG | A fragrance composition |
BR112017002061A2 (en) | 2014-08-15 | 2017-12-26 | Procter & Gamble | oral treatment compositions and regimens |
CN106659650A (en) | 2014-08-15 | 2017-05-10 | 宝洁公司 | Oral care compositions with an enhanced sensory experience |
CN111939090A (en) | 2014-08-15 | 2020-11-17 | 宝洁公司 | Dentifrice with extending chemical |
EP3023090B1 (en) | 2014-11-21 | 2019-08-07 | Symrise AG | Compositions |
KR20170070196A (en) | 2014-11-26 | 2017-06-21 | 더 질레트 컴퍼니 엘엘씨 | A skin engaging member comprising ethylene vinyl acetate |
CA2971390A1 (en) | 2014-12-18 | 2016-06-23 | The Gillette Company Llc | Lubricating members having hydrophobic components for razor cartridges |
RU2017118504A (en) | 2014-12-18 | 2019-01-18 | Дзе Жиллетт Компани Ллс | Lubricating elements for shaving cartridges |
EP3045161A1 (en) | 2015-01-18 | 2016-07-20 | Symrise AG | Active compositions comprising 1,2-hexanediol and 1,2-octanediol |
US9951295B2 (en) | 2015-02-19 | 2018-04-24 | The Procter & Gamble Company | Compositions for deposition on biological surfaces |
CN107532063B (en) * | 2015-03-25 | 2020-03-10 | 高砂香料工业株式会社 | Methylmenthol derivative and cold-sensitive composition containing the same |
EP3280411B1 (en) | 2015-04-09 | 2020-02-19 | The Procter and Gamble Company | Reduction in cpc taste aversion by reducing cpc activation of trpa1 receptors, tprv1 receptors, or both |
EP3081207B1 (en) | 2015-04-16 | 2022-09-21 | Symrise AG | Use of a liposome composition |
US10391071B2 (en) | 2015-04-28 | 2019-08-27 | Cutech Srl | Compositions comprising valerian extracts |
EP3097905B1 (en) | 2015-05-28 | 2020-11-04 | Symrise AG | Cosmetic compositions |
BR112018006735A2 (en) * | 2015-10-22 | 2018-10-16 | Procter & Gamble | chromatographic separation method |
MX2018004814A (en) | 2015-10-22 | 2019-04-01 | Procter & Gamble | Synthesis of cyclohexane carboxamide derivatives useful as sensates in consumer products. |
WO2017071752A1 (en) | 2015-10-28 | 2017-05-04 | Symrise Ag | Method for inhibiting or masking fishy odours |
MX2018005796A (en) | 2015-11-15 | 2018-08-01 | Symrise Ag | Reduction of stinging sensation on skin. |
WO2017097434A1 (en) | 2015-12-06 | 2017-06-15 | Symrise Ag | A fragrance composition |
WO2017097362A1 (en) | 2015-12-10 | 2017-06-15 | Symrise Ag | Composition with stabilized taste and odor |
EP3390352A1 (en) | 2015-12-18 | 2018-10-24 | The Procter and Gamble Company | Synthesis of cyclohexane ester derivatives useful as sensates in consumer products |
ES2733201T3 (en) | 2015-12-21 | 2019-11-28 | Thiocyn Gmbh | Cosmetic composition comprising a combination of active substances |
EP3090727B8 (en) | 2016-01-13 | 2019-06-19 | Thiocyn GmbH | Hair growth composition |
KR20180124121A (en) | 2016-03-30 | 2018-11-20 | 시므라이즈 아게 | Active mixture |
AU2017240032B2 (en) | 2016-04-01 | 2019-07-18 | The Procter & Gamble Company | Oral care compositions containing gel networks and potassium nitrate |
WO2017173272A1 (en) | 2016-04-01 | 2017-10-05 | The Procter & Gamble Company | Oral care compositions containing potassium nitrate and peroxide |
MX2018011991A (en) | 2016-04-01 | 2019-02-13 | Procter & Gamble | Oral care compositions with an effective flavor display. |
US20170334082A1 (en) | 2016-05-18 | 2017-11-23 | The Gillette Company Llc | Skin Engaging Member Comprising Ethylene Vinyl Acetate |
US20230190633A1 (en) | 2016-05-23 | 2023-06-22 | Symrise Ag | A wheat bran extract in a hair care blend |
WO2018036625A1 (en) | 2016-08-20 | 2018-03-01 | Symrise Ag | A preservative mixture |
BR112018073863B1 (en) | 2016-10-11 | 2022-08-23 | Symrise Ag | USE OF A COMPOUND OF FORMULA (I), ANTIFUNGAL MIXTURE, COMPOSITIONS COMPRISING SUCH COMPOUND OF FORMULA (I) OR SUCH ANTIFUNGAL MIXTURE AND METHOD TO PREVENT MICROBIAL DETERIORATION OF SUCH COMPOSITIONS |
WO2018081190A1 (en) | 2016-10-25 | 2018-05-03 | The Procter & Gamble Company | Fibrous structures |
US20180117780A1 (en) | 2016-11-03 | 2018-05-03 | The Gillette Company Llc | Skin engaging member comprising ethylene vinyl acetate |
BR112019009754B1 (en) | 2016-11-17 | 2022-11-22 | The Gillette Company Llc | SKIN CONTACT MEMBERS COMPRISING ETHYLENE VINYL ACETATE AND A FRAGRANCE |
WO2018099570A1 (en) | 2016-12-02 | 2018-06-07 | Symrise Ag | Cosmetic blends |
WO2018148763A1 (en) | 2017-02-13 | 2018-08-16 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
IT201700090929A1 (en) | 2017-08-07 | 2019-02-07 | Cutech S R L | Cosmetic and medical uses of extracts of Coprinus comatus fungus for the regulation of pilo sebaceous unity. |
EP4331684A2 (en) | 2017-08-09 | 2024-03-06 | Symrise AG | 1,2-alkanediols |
WO2019037844A1 (en) | 2017-08-23 | 2019-02-28 | Symrise Ag | Novel compositions of natural butters and uses thereof |
CN111032015A (en) | 2017-08-23 | 2020-04-17 | 西姆莱斯有限公司 | New use of extract of Isochrysis galbana |
KR102637288B1 (en) | 2017-10-10 | 2024-02-16 | 시므라이즈 아게 | Compositions containing benzoic acid derivatives or furoic acid derivatives and uses of the derivatives for emulsion and foam stability |
EP3700352B1 (en) | 2017-10-23 | 2021-09-22 | Symrise AG | Aroma composition |
JP6981243B2 (en) * | 2017-12-27 | 2021-12-15 | ライオン株式会社 | Toothpaste composition |
EP3813795A1 (en) | 2018-03-08 | 2021-05-05 | Symrise AG | Mixtures comprising a protein extract for the treatment of human skin and/or hair |
EP3823455A1 (en) | 2018-07-16 | 2021-05-26 | Symrise AG | Composition for substituting sugar in baked goods |
US20210337793A1 (en) | 2018-08-27 | 2021-11-04 | Symrise Ag | Antimicrobial mixtures comprising at least one hydroxyphenone derivative |
CN113226267A (en) | 2018-09-14 | 2021-08-06 | 西姆莱斯股份公司 | Hair care composition |
CA3113475A1 (en) | 2018-09-20 | 2020-03-26 | Symrise Ag | Compositions comprising odorless 1,2-pentanediol |
EP3860585A4 (en) | 2018-10-01 | 2022-06-22 | Wintermute Biomedical, Inc. | Therapeutic compositions |
WO2020069762A1 (en) | 2018-10-05 | 2020-04-09 | Symrise Ag | A method for fighting female body odors |
JP2020070263A (en) * | 2018-11-01 | 2020-05-07 | ライオン株式会社 | Liquid composition for oral cavity |
CN113164792A (en) | 2018-11-02 | 2021-07-23 | 西姆莱斯股份公司 | Liquid transparent mixtures of UV filters |
EP3877494A1 (en) | 2018-11-08 | 2021-09-15 | Symrise AG | An antimicrobial surfactant based composition |
KR20210117294A (en) | 2019-01-17 | 2021-09-28 | 시므라이즈 아게 | antibacterial mixture |
US20220071933A1 (en) | 2019-01-18 | 2022-03-10 | Symrise Ag | Combination remedy |
CN113891750A (en) | 2019-03-11 | 2022-01-04 | 西姆莱斯股份公司 | Method for improving performance of spice or spice mixture |
CA3131978A1 (en) | 2019-03-12 | 2020-09-17 | Symrise Ag | An antimicrobial mixture |
CN113766911A (en) | 2019-03-22 | 2021-12-07 | 西姆莱斯股份公司 | Plant peptides and uses thereof (II) |
WO2020192865A1 (en) | 2019-03-22 | 2020-10-01 | Symrise Ag | Plant peptides and their applications |
CN113993500A (en) | 2019-06-13 | 2022-01-28 | 德国德之馨香精香料公司 | Cool preparation |
EP3993767A1 (en) | 2019-07-02 | 2022-05-11 | Symrise AG | Blend of beeswax and a lactylate ester |
CN114364773A (en) | 2019-09-04 | 2022-04-15 | 西姆莱斯股份公司 | Aromatic oil mixture |
JP2023510996A (en) | 2019-10-16 | 2023-03-16 | シムライズ アーゲー | Non-disposable multi-use product intended for indirect penetration of active agents into the skin |
WO2021228352A1 (en) | 2020-05-11 | 2021-11-18 | Symrise Ag | A fragrance composition |
EP4149419A1 (en) | 2020-05-11 | 2023-03-22 | Symrise AG | A solid mucoadhesive composition |
MX2023003549A (en) | 2020-09-28 | 2023-04-21 | Procter & Gamble | Oral care composition comprising hops and flavor. |
WO2022111793A1 (en) | 2020-11-24 | 2022-06-02 | Symrise Ag | Medicament for accelerated wound healing |
WO2022111829A1 (en) | 2020-11-30 | 2022-06-02 | Symrise Ag | Essential oils of citrus fruits for use as medicament for induced, increased and/or accelerated autophagy in human keratinocytes |
WO2022122122A1 (en) | 2020-12-08 | 2022-06-16 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (i) |
WO2022122134A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions with (bio)-alkanediols and cooling agents |
WO2022122167A1 (en) | 2020-12-11 | 2022-06-16 | Symrise Ag | Medicament for preventing or treating pathologic conditions of human skin (i) |
WO2022128051A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (ii) |
WO2022128052A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin |
WO2022128048A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for preventing or treating pathologic conditions of human skin |
WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
WO2022128057A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for prevention and treatment of collagen degradation in human connecting tissue |
WO2022128050A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammation and pain |
WO2022161593A1 (en) | 2021-01-26 | 2022-08-04 | Symrise Ag | Medicament for accelerated wound healing |
WO2022171292A1 (en) | 2021-02-12 | 2022-08-18 | Symrise Ag | Medicament for prevention and treatment of hyperpigmentation |
WO2022214187A1 (en) | 2021-04-08 | 2022-10-13 | Symrise Ag | An o/w emulsion base and emulsions comprising the same |
WO2022218505A1 (en) | 2021-04-13 | 2022-10-20 | Symrise Ag | A fragrance mixture containing isocitronellol |
EP4326251A1 (en) | 2021-04-19 | 2024-02-28 | Symrise AG | Compositions comprising cannabidiol and, optionally, bisabolol |
EP4083050A1 (en) | 2021-05-01 | 2022-11-02 | Analyticon Discovery GmbH | Microbial glycolipids |
US20220370334A1 (en) | 2021-05-11 | 2022-11-24 | The Procter & Gamble Company | Oral Care Compositions Comprising Block Copolymer |
Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1351762A (en) | 1971-02-14 | 1974-05-01 | Wilkinson Sword Ltd | Tobacco and tobacco-containing manufactures |
GB1351761A (en) | 1971-02-04 | 1974-05-01 | Wilkinson Sword Ltd | Substituted p-menthane carboxamides and compositions containing them |
GB1353381A (en) | 1971-02-04 | 1974-05-15 | Wilkinson Sword Ltd | Substituted p-menthanes and compositions containing them |
GB1421744A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Aliphatic n-substituted tertiary amides possessing physiological cooling activity |
GB1457671A (en) | 1974-01-31 | 1976-12-08 | Wilkinson Sword Ltd | Flavour |
US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4226988A (en) | 1971-02-04 | 1980-10-07 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4248859A (en) | 1973-12-12 | 1981-02-03 | Wilkinson Sword Limited | Alicyclic amides having a physiological cooling effect |
US4296093A (en) | 1973-04-16 | 1981-10-20 | Wilkinson Sword Limited | Cyclic carboxamides having a physiological cooling effect |
US6348625B1 (en) | 2000-11-10 | 2002-02-19 | Gloria Long Anderson | Method for preparing some 1-adamantancecarboxamides |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
WO2004089416A2 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
WO2005002582A2 (en) | 2003-07-02 | 2005-01-13 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
WO2005015158A2 (en) | 2003-08-06 | 2005-02-17 | Senomyx Inc. | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
WO2005020897A2 (en) | 2003-08-22 | 2005-03-10 | Dendreon Corporation | Compositions and methods for the treatment of disease associated with trp-p8 expression |
US20050084447A1 (en) | 2003-10-15 | 2005-04-21 | Wei Edward T. | Radioligands for the TRP-M8 receptor and methods therewith |
US20050159394A1 (en) | 2003-12-31 | 2005-07-21 | Wei Edward T. | Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
US20050187211A1 (en) | 2004-02-23 | 2005-08-25 | Wei Edward T. | N-arylsalkyl-carboxamide compositions and methods |
US20050207993A1 (en) | 2003-11-13 | 2005-09-22 | Russel Bazemore | Method and composition for breath freshening |
US20060051301A1 (en) | 2002-10-28 | 2006-03-09 | Givaudan Sa | Coolant solutions and compositions comprising the same |
WO2006056087A1 (en) | 2004-11-23 | 2006-06-01 | Givaudan Sa | Carboxamides and their use |
WO2006056096A1 (en) | 2004-11-29 | 2006-06-01 | Givaudan Sa | Substrate care product |
WO2006092074A1 (en) | 2005-03-01 | 2006-09-08 | Givaudan Sa | Menthane carboxamide derivatives having cooling properties |
WO2006099762A1 (en) | 2005-03-24 | 2006-09-28 | Givaudan Sa | Cooling compounds |
WO2006125334A1 (en) | 2005-05-27 | 2006-11-30 | Givaudan Sa | Cooling compounds |
WO2007019719A1 (en) | 2005-08-15 | 2007-02-22 | Givaudan Sa | Cooling compounds |
US20080176945A1 (en) | 2005-03-02 | 2008-07-24 | Galopin Christophe C | Carboxilic Acid Amides Provoking A Cooling Sensation |
WO2009007091A2 (en) | 2007-07-09 | 2009-01-15 | Bayer Bioscience N.V. | Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
WO2009070910A2 (en) | 2007-12-07 | 2009-06-11 | Givaudan Sa | Carboxamide derivatieves having cooling properties |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2134977C (en) * | 1992-05-18 | 1998-12-15 | Deanna K. Furman | Coolant compositions |
BRPI0113421B8 (en) * | 2000-08-24 | 2016-05-10 | Givaudan Sa | use of unsubstituted p-menthane carboxamide compounds as insect repellent |
CN1845741A (en) * | 2003-07-02 | 2006-10-11 | 健泰科生物技术公司 | TRP-P8 active compounds and therapeutic treatment methods |
-
2004
- 2004-10-28 JP JP2006540126A patent/JP4786544B2/en active Active
- 2004-10-28 EP EP04761978A patent/EP1685093B3/en active Active
- 2004-10-28 WO PCT/CH2004/000646 patent/WO2005049553A1/en not_active Application Discontinuation
- 2004-10-28 PL PL04761978T patent/PL1685093T6/en unknown
- 2004-10-28 ES ES04761978T patent/ES2342466T7/en active Active
- 2004-10-28 CN CN200480033221A patent/CN100582089C/en active Active
- 2004-10-28 DE DE602004026619T patent/DE602004026619D1/en active Active
- 2004-10-28 BR BRPI0416770-8A patent/BRPI0416770B1/en active IP Right Grant
- 2004-10-28 AT AT04761978T patent/ATE464283T1/en not_active IP Right Cessation
-
2006
- 2006-05-19 US US11/437,294 patent/US7414152B2/en not_active Ceased
-
2011
- 2011-08-31 US US13/222,947 patent/USRE44339E1/en active Active
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1351761A (en) | 1971-02-04 | 1974-05-01 | Wilkinson Sword Ltd | Substituted p-menthane carboxamides and compositions containing them |
GB1353381A (en) | 1971-02-04 | 1974-05-15 | Wilkinson Sword Ltd | Substituted p-menthanes and compositions containing them |
US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4226988A (en) | 1971-02-04 | 1980-10-07 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
GB1351762A (en) | 1971-02-14 | 1974-05-01 | Wilkinson Sword Ltd | Tobacco and tobacco-containing manufactures |
GB1421744A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Aliphatic n-substituted tertiary amides possessing physiological cooling activity |
US4296093A (en) | 1973-04-16 | 1981-10-20 | Wilkinson Sword Limited | Cyclic carboxamides having a physiological cooling effect |
US4318900A (en) | 1973-12-12 | 1982-03-09 | Wilkinson Sword Limited | Alicyclic amides having a physiological cooling effect |
US4248859A (en) | 1973-12-12 | 1981-02-03 | Wilkinson Sword Limited | Alicyclic amides having a physiological cooling effect |
GB1457671A (en) | 1974-01-31 | 1976-12-08 | Wilkinson Sword Ltd | Flavour |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
US6348625B1 (en) | 2000-11-10 | 2002-02-19 | Gloria Long Anderson | Method for preparing some 1-adamantancecarboxamides |
US20060051301A1 (en) | 2002-10-28 | 2006-03-09 | Givaudan Sa | Coolant solutions and compositions comprising the same |
WO2004089416A2 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
WO2005002582A2 (en) | 2003-07-02 | 2005-01-13 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
WO2005015158A2 (en) | 2003-08-06 | 2005-02-17 | Senomyx Inc. | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
WO2005020897A2 (en) | 2003-08-22 | 2005-03-10 | Dendreon Corporation | Compositions and methods for the treatment of disease associated with trp-p8 expression |
US20050084447A1 (en) | 2003-10-15 | 2005-04-21 | Wei Edward T. | Radioligands for the TRP-M8 receptor and methods therewith |
US20050207993A1 (en) | 2003-11-13 | 2005-09-22 | Russel Bazemore | Method and composition for breath freshening |
US20050159394A1 (en) | 2003-12-31 | 2005-07-21 | Wei Edward T. | Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
US20050187211A1 (en) | 2004-02-23 | 2005-08-25 | Wei Edward T. | N-arylsalkyl-carboxamide compositions and methods |
US20080112899A1 (en) | 2004-11-23 | 2008-05-15 | Galopin Christophe C | Carboxamides and Their Use |
WO2006056087A1 (en) | 2004-11-23 | 2006-06-01 | Givaudan Sa | Carboxamides and their use |
WO2006056096A1 (en) | 2004-11-29 | 2006-06-01 | Givaudan Sa | Substrate care product |
US20080305051A1 (en) | 2005-03-01 | 2008-12-11 | Lucienne Cole | Menthane Carboxamide Derivatives Having Cooling Properties |
WO2006092074A1 (en) | 2005-03-01 | 2006-09-08 | Givaudan Sa | Menthane carboxamide derivatives having cooling properties |
US20080176945A1 (en) | 2005-03-02 | 2008-07-24 | Galopin Christophe C | Carboxilic Acid Amides Provoking A Cooling Sensation |
WO2006099762A1 (en) | 2005-03-24 | 2006-09-28 | Givaudan Sa | Cooling compounds |
US20080319055A1 (en) | 2005-03-24 | 2008-12-25 | Givaudan Sa | Cooling Compounds |
WO2006125334A1 (en) | 2005-05-27 | 2006-11-30 | Givaudan Sa | Cooling compounds |
US20090105237A1 (en) | 2005-05-27 | 2009-04-23 | Karen Ann Bell | Cooling compounds |
WO2007019719A1 (en) | 2005-08-15 | 2007-02-22 | Givaudan Sa | Cooling compounds |
US20100035938A1 (en) | 2005-08-15 | 2010-02-11 | Karen Ann Bell | Cooling Compounds |
WO2009007091A2 (en) | 2007-07-09 | 2009-01-15 | Bayer Bioscience N.V. | Brassica plant comprising mutant fatty acyl-acp thioesterase alleles |
WO2009070910A2 (en) | 2007-12-07 | 2009-06-11 | Givaudan Sa | Carboxamide derivatieves having cooling properties |
Non-Patent Citations (10)
Title |
---|
Database Beilstein, Beilstein Insitut zur Förderung der Chemischen Wissenschaften; XP002382093 accession No. 3422960, abstract & BUU-HOI: Z. Physiol. Chem., vol. 279, 1943. |
Database Beilstein, Beilstein Institut zur Förderung der Chemischen Wissenschaften; XP002382094 accession No. 2328224, abstract & Inagaki, Shingaki: Chem. Lett., 1981. |
Database Chemcats, Accession NR. 2004:1396439: ChemBridge Screening Library, Order NR. 5380996, Jan. 12, 2005, XP 002384344, abstract. |
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382091, order No. 6383438, abstract. |
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382092, order No. 6399044, abstract. |
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 18, 2005, XP002382089, order No. STK013323, abstract. |
Database Chemcats, Chemical Abstracts Service, Columbus, Ohio, US; Jan. 18, 2005, XP002382090, order No. BAS 08858028, abstract. |
Database Chemicals [Online], Chemical Abstracts Service, Columbus, Ohio, US; Jan. 12, 2005, XP002382088, retrieved from STN, order No. 6489078, abstract. |
Patani et al., Chemical Review, 1996, vol. 96, pp. 3147-3176. |
Watson H.R., et al., "New Compounds with the Menthol Cooling Effect," Journal of Society of Cosmetic Chemists, New York, NY, U.S., vol. 29, No. 4, 1978, pp. 185-200. |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US10596086B2 (en) | 2012-06-21 | 2020-03-24 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antibacterials |
US11253451B2 (en) | 2012-06-21 | 2022-02-22 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antibacterials |
US11236042B2 (en) | 2017-01-10 | 2022-02-01 | Takasago International Corporation | Methylmenthol derivative and cool-sensation imparter composition containing same |
US11344488B2 (en) | 2017-10-16 | 2022-05-31 | Takasago International Corporation | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative |
US10871363B2 (en) | 2018-05-28 | 2020-12-22 | The Procter & Gamble Company | Oral care composition with improved deposition efficacy of a cooling sensate agent in the oral cavity |
US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
US11826452B2 (en) | 2019-04-26 | 2023-11-28 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
Also Published As
Publication number | Publication date |
---|---|
ATE464283T1 (en) | 2010-04-15 |
US20060276667A1 (en) | 2006-12-07 |
BRPI0416770B1 (en) | 2014-05-13 |
PL1685093T3 (en) | 2010-10-29 |
BRPI0416770A (en) | 2007-02-27 |
CN1878746A (en) | 2006-12-13 |
EP1685093B1 (en) | 2010-04-14 |
CN100582089C (en) | 2010-01-20 |
EP1685093A1 (en) | 2006-08-02 |
JP4786544B2 (en) | 2011-10-05 |
JP2007511546A (en) | 2007-05-10 |
PL1685093T6 (en) | 2012-10-31 |
EP1685093B3 (en) | 2012-04-11 |
ES2342466T7 (en) | 2012-11-19 |
WO2005049553A1 (en) | 2005-06-02 |
ES2342466T3 (en) | 2010-07-07 |
DE602004026619D1 (en) | 2010-05-27 |
US7414152B2 (en) | 2008-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE44339E1 (en) | N-substituted P-menthane carboxamides | |
US11059783B2 (en) | Pyridinyl cyclohexanecarboxamide cooling compounds | |
US20080319055A1 (en) | Cooling Compounds | |
US7893110B2 (en) | Carboxylic acid amides provoking a cooling sensation | |
EP2167024B1 (en) | Cooling compounds | |
US20080112899A1 (en) | Carboxamides and Their Use | |
US8263046B2 (en) | N-phenyl-N-pyridinyl-benzamides and benzenesulfonomides having cooling properties | |
US8377422B2 (en) | Carboxamide derivatives having cooling properties | |
EP1853565B1 (en) | Menthane carboxamide derivatives having cooling properties | |
US7935848B2 (en) | Butone derivatives useful as cooling agents | |
US20090035364A1 (en) | Para-substituted 2-alkoxyphenol compounds | |
US20100297038A1 (en) | Benzimidazole Derivatives And Their Use As Cooling Agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |